Published today in the Journal of the Royal Society of Medicine, this comprehensive systematic review assessed the effects of interventions used to treat, manage and rehabilitate patients with chronic fatigue syndrome/ myalgic encephalomyelitis (CFS/ME)
The review examined the research evidence on behavioural, immunological, pharmacological, complementary therapies and nutritional supplements used to treat, manage and rehabilitate patients with CFS/ME. Overall, the interventions assessed demonstrated mixed results in terms of beneficial effects.
Cognitive behavioural therapy and graded exercise therapy can be effective interventions
Immunological and anti-viral treatments may have beneficial effects but are associated with harmful side-effects.
Most drug treatments have not shown beneficial effects.
CFS/ME comprises a range of symptoms including fatigue, which can be triggered by minimal activity, malaise, headaches, sleep disturbances, difficulties with concentration and muscle pain. In extreme cases, CFS/ME can cause profound, prolonged illness and disability, and can have a substantial impact on patients and their families.
Like other chronic illnesses with no certain disease process, CFS/ME poses real problems for healthcare professionals. It has been estimated that a typical general practice of 10,000 patients is likely to have at least 30-40 patients with CFS/ME, and that about half of these would require specialist services.
This systematic review was commissioned by the National Institute for Health and Clinical Excellence (NICE) to inform the development of their guidelines for the diagnosis and management of CFS/ME in adults and children. The draft guidance is due to be released for public consultation on the 29 September 2006.
Paul Wilson | alfa
Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign
Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences